Table 1.

Percentage of survival by a panel of 14 NTHi COPD clinical isolates, when incubated with increasing concentrations of resveratrol. Values denoted are mean ± SD.

NTHi strain	Resveratrol (μg/ml)
	175	75	25	8.33
P617–9224	35 ± 11	62.8 ± 14.6	87.9 ± 16.9	98.9 ± 2
P621–7028	24.6 ± 15.2	56 ± 8.3	72.6 ± 19.1	80.8 ± 19.4
P636–8296	23.4 ± 6.9	47.5 ± 22.9	79.7 ± 21	95.6 ± 5.5
P642–4396	22.4 ± 4.5	46.2 ± 6.4	56.4 ± 11.5	73 ± 16.5
P595–8370	31.5 ± 15.5	65.8 ± 9.8	86.2 ± 14.8	90 ± 11.5
P615–8618	11 ± 8	40.3 ± 11.7	52.2 ± 16.5	82 ± 18.5
P650–8603	10.8 ± 4.3	50.8 ± 15.4	81.7 ± 18.3	95.5 ± 7.2
P652–8881	4.8 ± 9.5	42.5 ± 18.4	73.7 ± 19.5	88.3 ± 16.4
P662–7189	15 ± 8.4	40 ± 5.9	61.1 ± 11.7	79.2 ± 12.1
P657–8759	23.6 ± 12.3	60 ± 18.9	83.1 ± 16.3	86 ± 14.1
P665–7858	1.1 ± 2.7	70.7 ± 25	90.1 ± 17	88.5 ± 17.5
P669–6977	24 ± 8.9	57.8 ± 9.6	76.7 ± 10.7	89.8 ± 10.4
P672–7661	2.6 ± 3.2	34.3 ± 10.2	87.4 ± 14.5	96.6 ± 6.8
P679–2791	38.4 ± 10.6	62.4 ± 20.3	74.9 ± 17.8	87 ± 13.2